FEM1B enhances TRAIL ‐induced apoptosis in T lymphocytes and monocytes
FEBS Open Bio · 2025
DOI: 10.1002/2211-5463.70056 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, 2025. Verfasst von Chenbo Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Human Disease Comparative Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Beijing Key Laboratory for A…. Hauptthemen laut MEDLINE: Apoptosis, Monocytes, TNF-Related Apoptosis-Inducing Ligand, T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Project of China, Beijing Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
FEM1B is recognized for its significant pro‐apoptotic function in colorectal cancer; however, its influence and mechanisms regarding apoptosis in immune cells remain inadequately elucidated. In this study, we demonstrated that FEM1B enhances TRAIL‐induced apoptosis in Molt‐4, Jurkat, THP‐1, and U937 cell lines. Notably, the knockdown of FEM1B in transfected cells resulted in a reversal of the observed increase in cell apoptosis. Our findings indicate that FEM1B activates caspase‐3 and caspase‐8, but not caspase‐9, in response to TRAIL stimulation, suggesting its involvement in the extrinsic caspase‐dependent apoptotic pathway. Furthermore, we found that FEM1B interacted with TRAF2 and downregulates its expression in Molt‐4 and Jurkat cells, thereby diminishing TRAF2's inhibitory effect on caspase‐8. In THP‐1 and U937 cells, FEM1B was found to upregulate TRAIL‐R2, thereby promoting TRAIL‐induced apoptosis. Knockout studies in murine models further corroborated that FEM1B facilitates TRAIL‐induced apoptosis. These results demonstrate that FEM1B enhances TRAIL‐induced apoptosis in T lymphocytes and monocytes through a caspase‐dependent mechanism involving TRAF2 or TRAIL receptors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Human Disease Comparative Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute…
- Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Förderung
- National Key Research and Development Project of China
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Yang, C., Yu, W., Dang, C., Zhang, J., Lu, J., & Xue, J. (2025). FEM1B enhances TRAIL ‐induced apoptosis in T lymphocytes and monocytes. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70056
Vancouver
Yang C, Yu W, Dang C, Zhang J, Lu J, Xue J. FEM1B enhances TRAIL ‐induced apoptosis in T lymphocytes and monocytes. FEBS Open Bio. 2025. doi:10.1002/2211-5463.70056
BibTeX
@article{Yang2025,
author = {Yang, Chenbo and Yu, Wenhui and Dang, Cui and Zhang, Jingjing and Lu, Jiahan and Xue, Jing},
title = {FEM1B enhances TRAIL ‐induced apoptosis in T lymphocytes and monocytes},
journal = {FEBS Open Bio},
year = {2025},
doi = {10.1002/2211-5463.70056}
}
EUVIMED